Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.4200
-0.0780 (-15.66%)
Nov 18, 2025, 9:30 AM EST
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $1.94 million as of November 19, 2025. Its market cap has decreased by -48.15% in one year.
Market Cap
1.94M
Enterprise Value
349.06K
Revenue
389.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.42
Market Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 1.94M, a decrease of -92.83%. That is a compound annual growth rate of -59.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 1.94M | -47.37% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
| Dec 20, 2022 | 27.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 807.30M |
| Elite Pharmaceuticals | 624.11M |
| Glass House Brands | 451.06M |
| American Oncology Network | 369.77M |
| CytoDyn | 362.81M |
| Northwest Biotherapeutics | 355.00M |
| Silence Therapeutics | 316.47M |
| Nika Pharmaceuticals | 311.89M |